1320. In Vitro Activity of Lefamulin against Staphylococcus aureus Isolated from the Lower Respiratory Tract of Children with Cystic Fibrosis

BACKGROUND: Lefamulin is a first-in-class, oral and IV pleuromutilin antibiotic approved in the US, EU, and Canada for the treatment of community-acquired bacterial pneumonia (CABP) in adults. Lefamulin inhibits bacterial protein synthesis via a unique mechanism of action and its potency against S....

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Paukner, Susanne, Gelone, Steven P, Arends, S J Ryan, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643990/
http://dx.doi.org/10.1093/ofid/ofab466.1512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643990/
http://dx.doi.org/10.1093/ofid/ofab466.1512

Ejemplares similares